Quantum Simulation Technologies key facts
as of Oct 2026- Developer of quantitative simulation tools designed to help in quantum molecular simulations in the cloud.
- Quantum Simulation Technologies is valued at approximately $23.0M as of Oct 2026, set at its seed round, Oct 2025; nothing has traded since, per PrivateMarketView’s mark.
- It has raised $11.1M across 3 recorded rounds; the latest was Early Stage VC ($5.8M) in Mar 2021.
- Notable investors include US National Science Foundation, U.S. Department of Energy, UTokyo Innovation Platform Company, Kyoto University Innovation Capital, Embark Ventures — 10 tracked in total.
- Quantum Simulation Technologies has filed 3 Form Ds with the SEC since 2019, most recently Apr 2021 ($5.8M sold to 9 investors).
- Status: Privately Held (backing).
Valued at $23.0M at its seed round, Oct 2025. Nothing has traded since.
- ·Watch Quantum Simulation Technologies: the Monday email on marks, rounds and moves
Quantum Simulation Technologies funding rounds
3 roundsQuantum Simulation Technologies valuation
Quantum Simulation Technologies was valued at $23 million at its seed round in Oct 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Quantum Simulation Technologies raised?
Quantum Simulation Technologies has raised $11.1 million across 3 recorded rounds since 2019. The largest was a $750,000 seed round in Aug 2019; the most recent was a $5.8 million early-stage round in Mar 2021.
Quantum Simulation Technologies has filed 3 Form Ds with the SEC since 2019, most recently in Apr 2021 ($5.8 million sold to 9 investors).
Quantum Simulation Technologies investors
10 investors are on record for Quantum Simulation Technologies, including US National Science Foundation, U.S. Department of Energy, UTokyo Innovation Platform Company and Kyoto University Innovation Capital. The early-stage round in Mar 2021 drew 9 investors.
About Quantum Simulation Technologies
Developer of quantitative simulation tools designed to help in quantum molecular simulations in the cloud. The company's cloud-based simulation tools help the chemical and pharmaceutical industries solve industrial-scale problems and automate workflows, enabling clients to accelerate their research and development process.
- Sector
- Information Technology
- HQ
- Boston, MA, United States
- Founded
- 2018
- Employees
- 21
- Website
- qsimulate.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.